Post–hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics

Y Migdady, Y Pang, SS Kalsi, R Childs… - Blood Advances, 2022 - ashpublications.org
Anemia after allogeneic hematopoietic stem cell transplantation (HSCT) can be immune or
non–immune mediated. Auto-or alloimmunity resulting from blood group incompatibility …

[HTML][HTML] Fresh frozen plasma (FFP)

H Khawar, W Kelley, JB Stevens, N Guzman - 2018 - europepmc.org
Objectives: Identify the mechanism of action of fresh frozen plasma. Describe the adverse
effects of fresh frozen plasma. Review the appropriate monitoring of patients who are …

Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major …

P Mehta, S Ramprakash, CP Raghuram, D Trivedi… - Annals of …, 2021 - Springer
ABO incompatibility is not a barrier to allogeneic stem cell transplant but may result in acute
hemolytic reactions. As stem cell product manipulation is cumbersome, we are reporting the …

Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation

MC Finazzi, A Weber, C Pavoni, A Grassi… - Bone Marrow …, 2024 - nature.com
ABO-group major incompatibility hematopoietic stem cell transplantation (HSCT) increases
the risk of delayed red cell engraftment and other immunological complications. In this study …

The impact of infused red blood cell volume on major and bidirectional ABO-mismatched bone marrow transplantation

AB Araújo, T Schmalfuss, JM Furlan, D Speransa… - Cytotherapy, 2024 - Elsevier
Background aims ABO incompatibility does not hinder bone marrow transplantation (BMT),
but it has been associated with worse outcomes and additional adverse events. This study …

[PDF][PDF] Administration of daratumumab in the case of severe pure red cell aplasia after allogeneic transplantation

RR Bicsko, F Magyari, R Szasz, A Illes… - Ann Hematol …, 2021 - researchgate.net
Pure red cell aplasia is a well-known complication of AB0 major mismatched allogeneic
hematopoietic stem cell transplantation. This side effect can be selflimiting, but is …

Clinico-laboratory outcomes of plasma transfusion in the Egyptian's pediatric intensive care units—a prospective observational study

MAAE Megied, LH Mohamed, BSS Meligy… - Egyptian Pediatric …, 2023 - Springer
Background Despite the paucity of data supporting their indications, plasma transfusions
(PT) are regularly administered for critically ill patients (CIP) in pediatric intensive care units …

ABO Mismatched Stem Cell Transplant and Related Complications

SK Sharma - Basics of Hematopoietic Stem Cell Transplant, 2023 - Springer
ABO compatibility between the donor and the recipient plays an important role in terms of
getting the most compatible blood during the peri-transplant period and can have …

Coagulation Management in End-Stage Liver Disease

SS Shettar, K Vandyck, KA Tanaka - Current Anesthesiology Reports, 2022 - Springer
Abstract Purpose of Review There is a precarious and altered balance in the hemostatic
function encountered in patients with end-stage liver disease (ESLD). Anesthetic …

[HTML][HTML] Management of stem cell transplantation with major ABO blood group incompatibility: Pure Red cell aplasia

M Soleimani, F Tavakoli, M Ghadyani… - Scientific Journal of …, 2022 - bloodjournal.ir
Management of stem cell transplantation with major ABO blood group incompatibility: Pure
Red cell aplasia - Scientific Journal of Iran Blood Transfus Organ - فصلنامه پژوهشی خون [Home …